Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia.

Chengfang Zhou, Mei Kuang, Zhilong Liu, Xiaoqin Jia, Zhe Chen, Yuanyuan Liu, Zhigang Li, Weiru Wu, Le Ma, Jieping Chen, Yu Hou

Leukemia 2022 Mar

filter terms:

FZR1 has been implicated as a master regulator of the cell cycle and quiescence, but its roles and molecular mechanisms in the pathogenesis of severe aplastic anemia (SAA) are unclear. Here, we report that FZR1 is downregulated in SAA HSCs compared with healthy control and is associated with decreased quiescence of HSC. Haploinsufficiency of Fzr1 shows impaired quiescence and self-renewal ability of HSC in two Fzr1 heterozygous knockout mouse models. Mechanistically, FZR1 insufficiency inhibits the ubiquitination of RUNX1 protein at lysine 125, leading to the accumulation of RUNX1 protein, which disturbs the quiescence of HSCs in SAA patients. Moreover, downregulation of Runx1 reversed the loss of quiescence and impaired long-term self-renew ability in Fzr1+/- HSCs in vivo and impaired repopulation capacity in BM from SAA patients in vitro. Our findings, therefore, raise the possibility of a decisive role of the FZR1-RUNX1 pathway in the pathogenesis of SAA via deregulation of HSC quiescence. © 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Citation

Chengfang Zhou, Mei Kuang, Zhilong Liu, Xiaoqin Jia, Zhe Chen, Yuanyuan Liu, Zhigang Li, Weiru Wu, Le Ma, Jieping Chen, Yu Hou. Insufficiency of FZR1 disturbs HSC quiescence by inhibiting ubiquitin-dependent degradation of RUNX1 in aplastic anemia. Leukemia. 2022 Mar;36(3):834-846